Dr. Reddy’s Q2 FY24 financial results show 9% YoY revenue growth
Dr. Reddy’s Laboratories Ltd., an Indian pharma major, has unveiled its robust performance metrics for the Q2 FY24, ending September 30, 2023. Under the guidelines ... Read More
Dr. Reddy’s Laboratories Q1 FY22 profit down by 1% to Rs 571cr
Dr. Reddy’s Laboratories has reported a 1% drop in its profit after tax for the first quarter of the fiscal year 2022 (Q1 FY22) to ... Read More
Dr. Reddy’s launches Sputnik V Covid vaccine in India at Rs 995 per dose
Dr. Reddy's Laboratories has launched the Sputnik V Covid vaccine in India with the first dose of the Russian vaccine administered today in Hyderabad. The ... Read More
Dr. Reddy’s seeks EUA for Russian Covid-19 vaccine Sputnik V from DCGI
Dr. Reddy’s Laboratories said that it has started the process to seek the emergency use authorization (EUA) for the Russian Covid-19 vaccine Sputnik V from ... Read More
Dr. Reddy’s Laboratories gets DCGI nod for phase 3 trial of Sputnik V Covid-19 vaccine
Dr. Reddy’s Laboratories has recently received approval from the Drugs Control General of India (DCGI) to proceed with the phase 3 clinical trial of the ... Read More
Dr. Reddy’s reports success in Sputnik V phase 2 trial, paving the way for phase 3 in India
Dr. Reddy’s Laboratories has announced a major milestone in the development of Sputnik V, the Russian Covid-19 vaccine, following its successful phase 2 clinical trial ... Read More
Dr. Reddy’s, RDIF to bring Sputnik V coronavirus vaccine to India
Russian Direct Investment Fund (RDIF) and Dr. Reddy’s Laboratories have agreed to cooperate on clinical trials and distribution of the Sputnik V coronavirus vaccine in ... Read More